This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2019 Jan 28;191(4):E103.

doi: 10.1503/cmaj.180881.

Mycoplasma genitalium infection

Ameeta E Singh¹, Annie-Claude Labbé², Ulrick Auguste²

Affiliations

Affiliations

¹ University of Alberta (Singh), Edmonton, Alta.; Université de Montréal (Labbé), Montréal, Que.; Public Health Agency of Canada (Auguste), Ottawa, Ont. ameeta@ualberta.ca.
² University of Alberta (Singh), Edmonton, Alta.; Université de Montréal (Labbé), Montréal, Que.; Public Health Agency of Canada (Auguste), Ottawa, Ont.

PMID: 30692107
PMCID: PMC6342694
DOI: 10.1503/cmaj.180881

Mycoplasma genitalium infection

Ameeta E Singh et al. CMAJ. 2019.

. 2019 Jan 28;191(4):E103.

doi: 10.1503/cmaj.180881.

Authors

Ameeta E Singh¹, Annie-Claude Labbé², Ulrick Auguste²

Affiliations

¹ University of Alberta (Singh), Edmonton, Alta.; Université de Montréal (Labbé), Montréal, Que.; Public Health Agency of Canada (Auguste), Ottawa, Ont. ameeta@ualberta.ca.
² University of Alberta (Singh), Edmonton, Alta.; Université de Montréal (Labbé), Montréal, Que.; Public Health Agency of Canada (Auguste), Ottawa, Ont.

PMID: 30692107
PMCID: PMC6342694
DOI: 10.1503/cmaj.180881

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

[Sexually transmitted Mycoplasma genitalium infection is difficult to treat].
Jensen JS, Salado-Rasmussen K. Jensen JS, et al. Ugeskr Laeger. 2018 May 14;180(20):V01180038. Ugeskr Laeger. 2018. PMID: 29798753 Review. Danish.
Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
Machalek DA, Tao Y, Shilling H, Jensen JS, Unemo M, Murray G, Chow EPF, Low N, Garland SM, Vodstrcil LA, Fairley CK, Hocking JS, Zhang L, Bradshaw CS. Machalek DA, et al. Lancet Infect Dis. 2020 Nov;20(11):1302-1314. doi: 10.1016/S1473-3099(20)30154-7. Epub 2020 Jul 2. Lancet Infect Dis. 2020. PMID: 32622378
High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands.
Braam JF, Slotboom B, Van Marm S, Severs TT, Van Maarseveen NM, Van Zwet T, Boel ECH, Berkhout H, Hagen F, Van De Bovenkamp JHB, Van Dommelen L, Kusters JG. Braam JF, et al. J Antimicrob Chemother. 2017 May 1;72(5):1529-1530. doi: 10.1093/jac/dkw584. J Antimicrob Chemother. 2017. PMID: 28158595 No abstract available.
Mycoplasma genitalium, an emerging sexually transmitted pathogen.
Cazanave C, Manhart LE, Bébéar C. Cazanave C, et al. Med Mal Infect. 2012 Sep;42(9):381-92. doi: 10.1016/j.medmal.2012.05.006. Epub 2012 Sep 10. Med Mal Infect. 2012. PMID: 22975074 Review.
Mycoplasma genitalium infection.
Pinto-Sander N, Soni S. Pinto-Sander N, et al. BMJ. 2019 Oct 18;367:l5820. doi: 10.1136/bmj.l5820. BMJ. 2019. PMID: 31628115 No abstract available.

See all similar articles

Cited by

Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches.
Manhart LE, Geisler WM, Bradshaw CS, Jensen JS, Martin DH. Manhart LE, et al. Emerg Infect Dis. 2022 Aug;28(8):e220094. doi: 10.3201/eid2808.220094. Emerg Infect Dis. 2022. PMID: 35876565 Free PMC article.

References

1. Jensen JS, Cusini M, Gomberg M, et al. Background review for the 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol 2016;30:1686–93. - PubMed
1. Gesink D, Racey CS, Seah C, et al. Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance. Can Fam Physician 2016;62:e96–101. - PMC - PubMed
1. Gratrix J, Plitt S, Turnbull L, et al. Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis. BMJ Open 2017;7:e016300. - PMC - PubMed
1. Chernesky MA, Jang D, Martin I, et al. Canadian MG Study Group. Mycoplasma genitalium antibiotic resistance-mediating mutations in Canadian women with or without Chlamydia trachomatis Infection. Sex Transm Dis 2017;44:433–5. - PubMed
1. Section 5-1: Canadian guidelines on sexually transmitted Infections — Management and treatment of specific infections — Mycoplasma genitalium Infections. Ottawa: Public Health Agency of Canada; (modified 2018 July 27). Available: www.canada.ca/en/public-health/services/infectious-diseases/sexual-healt... (accessed 2018 July 4).

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information